Skip to main content
Warning Date
    2015-03-03

SFDA warns from (Xian Ling) cosmetic for rheumatism which is had misleading claims

2015-03-03

​SFDA warned from (Xian Ling) cosmetic, which is marketed by normal shops or sold on social networking as a natural product for relieving the pain and rheumatism, while it carries misleading claims, and defraudation with two substances, which are causing negative effects and side symptoms.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Zino Coffee Product

Warning Date
    2018-11-11

SFDA Warns from Using “ Zino Coffee Product”

2018-11-11

 

 

SFDA Warned consumers from using ‘Zino Coffee’ product which is manipulated with pharmaceutical material and having false medical claims.

SFDA stated that the product is marketed by Itarat Stores and Websites as a natural and efficient product for curing several diseases. Analysis of the product by SFDA laboratories revealed that such claim is false and incorrect and faked with pharmaceutical materials.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2014-03-24

SFDA warns about medical claims of " Pama Herb Drench" produced by Nancy City Aofula Pharmaceutical Co. Ltd

2014-03-24

​SFDA would like to warn all consumers about the medical claims of (Bama Herb Drench), a herbal product from Nancy city Aofula pharmaceutical co. ltd, which dissolves in water and its soak is used for massaging legs. The product is promoted in some satellite channels and social networks and websites, as a remover of insomnia, joint pain, menstruation pain , exhaustion, headache, constipation and many medical claims . Such claims are found to be misleading and not true.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-06-27

إدارة صحة كندا تحذر المستهلكين من استخدام أقراص إنكور للرجال وذلك لاحتمالية خطورتها على الصحة

2007-06-27

قامت صحة كندا بتحذير المستهلكين من استخدام أقراص إنكور للرجال Encore Tabs for Men وذلك بسبب احتوائها على كميات غير مصرح بها من مركبات صيدلانية مماثلة لما يتم استخدامه في الأدوية المصرح باستخدامها وهي مادة تادالافيل tadalafil حيث يستخدم هذا الدواء بوصفة طبية لعلاج أمراض العجز الجنسي لدى الرجال والذي يجب استخدمه تحت إشراف طبي.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-06-30

FDA SAFETY ALERT OF USING COLISTIMETHATE SOLUTION FOR INHALATION WITH NEBULIZER

2007-06-30

FDA notified healthcare professionals and cystic fibrosis patients in U.S that the Agency is investigating the possible connection between the use of a liquid solution of Colistimethate that was premixed for inhalation with a nebulizer and the death of a patient with cystic fibrosis (CF).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2006-07-26

SSRIs and Treatment Challenges of Depression in Pregnancy

2006-07-26

FDA notified healthcare professionals and consumers of important information from two recent studies that should be considered when making treatment decisions in pregnant women who take antidepressants. The studies included pregnant women who were treated with selective serotonin reuptake inhibitors (SSRIs), or in a few cases, other antidepressant medications.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

FDA Warns Consumers About Dangerous Ingredients in "Dietary Supplements" Promoted for Sexual Enhancement

The U.S. Food and Drug Administration (FDA) is warning consumers not to purchase or consume Zimaxx, Libidus, Neophase, Nasutra, Vigor-25, Actra-Rx, or 4EVERON. These products are promoted and sold on web sites as "dietary supplements" for treating erectile dysfunction (ED) and enhancing sexual performance, but they are in fact illegal drugs that contain potentially harmful undeclared ingredients. These products have not been approved by FDA, and there is no guarantee of their safety and effectiveness, or of the purity of their ingredients.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

French health authorities ban cosmetics containing vitamin K1 (phytonadione)

The French Health Products Safety Agency (AFSSAPS) has announced a temporary ban on all cosmetic products containing vitamin K1 (INCI name: phytonadione; common name: phylloquinone; CAS: 84-80-0).

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2007-03-26

Heparin Sodium Injection 10,000 units/mL, and HEP-LOCK U/P 10 units/mL Medication Errors

2007-03-26

Audience: Pharmacists, neonatology/pediatric healthcare professionals

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Warning Date
    2006-09-30

Highly Drug-resistant Tuberculosis, Worldwide Warning Given

2006-09-30

New forms of highly drug-resistant tuberculosis are emerging and action must be taken soon before they become widespread globally, says an editorial in this week's british medical journal. The authors say that urgent action is needed to implement effective tuberculosis control strategies, especially in countries where tuberculosis control practices have been inadequate.

  • To report sector-related issues

  • Call Centre 19999


Other Warnings

Subscribe to Drugs